Patents by Inventor Mark Walden Lundy

Mark Walden Lundy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Skeletal removal of bisphosphonates
    Patent number: 11400104
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: August 2, 2022
    Assignees: The Regents of the University of California, BioVinc LLC, University of Southern California
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Skeletal Removal of Bisphosphonates
    Publication number: 20210121485
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Application
    Filed: October 29, 2020
    Publication date: April 29, 2021
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Skeletal removal of bisphosphonates
    Patent number: 10857165
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: December 8, 2020
    Assignees: The Regents of the University of California, BioVinc LLC, University of Southern California
    Inventors: Frank Hallock Ebetino, Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Skeletal Removal of Bisphosphonates
    Publication number: 20190209590
    Abstract: Disclosed herein are methods and compositions for removing or displacing bisphosphonates in skeletal tissue.
    Type: Application
    Filed: May 31, 2017
    Publication date: July 11, 2019
    Inventors: Frank Hallock Ebetino, Ph.D., Ichiro Nishimura, Shuting Sun, Mark Walden Lundy, Akishige Hokugo, Charles McKenna, Keivan Sadrerafi
  • Imidazo[1,2-a] pyridinyl bisphosphonates
    Patent number: 8618079
    Abstract: Novel imidazo[1,2-?]pyridinyl bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: December 31, 2013
    Assignee: Isis Innovation Limited
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • 5-azaindole bisphosphonates
    Patent number: 8252774
    Abstract: Novel 5-azaindole bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: August 28, 2012
    Assignee: Isis Innovation Ltd.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • 5-AZAINDOLE BISPHOSPHONATES
    Publication number: 20110237550
    Abstract: Novel 5-azaindole bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 29, 2011
    Applicant: ISIS INNOVATION LTD.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES
    Publication number: 20110230443
    Abstract: Novel imidazo[1,2-?]pyridinyl bisphosphonate compounds are disclosed, as well as methods of preparing the compounds, pharmaceutical compositions including the compounds, and administration of the compounds in methods of treating abnormal calcium and phosphate metabolism, including bone and joint diseases and other disorders.
    Type: Application
    Filed: September 22, 2009
    Publication date: September 22, 2011
    Applicant: ISIS INNOVATION LTD.
    Inventors: Frank Hallock Ebetino, Adam Mazur, Mark Walden Lundy, Robert Graham Russell
  • Method of increasing bone volume using non-naturally-occurring FP selective agonists
    Patent number: 6156799
    Abstract: The present invention relates to novel methods of increasing bone volume comprising the administration of a non-naturally-occurring selective FP agonist to a subject in need of such treatment. This invention further relates to a method of treating or preventing bone disorders comprising the administration of a non-naturally-occurring selective FP agonist to a subject in need of such treatment.
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: December 5, 2000
    Assignee: The Procter & Gamble Company
    Inventors: James Richard Hartke, Mark Walden Lundy, Mitchell Anthony deLong